These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 278469)

  • 21. Effect of insulin therapy on insulin resistance in type II diabetic subjects. Evidence for heterogeneity.
    Ginsberg H; Rayfield EJ
    Diabetes; 1981 Sep; 30(9):739-45. PubMed ID: 7021272
    [No Abstract]   [Full Text] [Related]  

  • 22. Circulating immune complexes in diabetes.
    Di Mario U; Iavicoli M; Andreani D
    Diabetologia; 1980 Aug; 19(2):89-92. PubMed ID: 6998823
    [No Abstract]   [Full Text] [Related]  

  • 23. Insulin antibodies and the control of diabetes.
    Dixon K; Exon PD; Malins JM
    Q J Med; 1975 Oct; 44(176):543-53. PubMed ID: 1105646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IgA- and insulin-containing (C3-fixing) circulating immune complexes in diabetes mellitus.
    Triolo G; Giardina E; Rinaldi A; Bompiani GD
    Clin Immunol Immunopathol; 1984 Feb; 30(2):169-77. PubMed ID: 6692599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anti-insulin antibodies in diabetes mellitus in children].
    Martynova MI; Ermolin GA; Smirnov VV; Galybin AA; Marchenko LF
    Pediatriia; 1988; (4):8-11. PubMed ID: 3060831
    [No Abstract]   [Full Text] [Related]  

  • 26. Letter: Glucagon antibodies in diabetic patients.
    Cresto JC; Lavine RL; Perrino P; Recant L; August G; Hung W
    Lancet; 1974 Jun; 1(7867):1165. PubMed ID: 4136911
    [No Abstract]   [Full Text] [Related]  

  • 27. [Leukocyte migration inhibition and antibody levels in diabetes mellitus].
    Rózsás Z; Horváth M; Karádi I; Bretán M
    Orv Hetil; 1981 Aug; 122(35):2157-9. PubMed ID: 7301376
    [No Abstract]   [Full Text] [Related]  

  • 28. [Sustained specific desensitization in a patient with diabetes mellitus with insulin allergy under conditions of immunoglobulin control].
    Dreval' AV; Mutina ES; Iuldashev AK; Serova TI; Sitnikova ND
    Probl Endokrinol (Mosk); 1978; 24(4):51-4. PubMed ID: 683971
    [No Abstract]   [Full Text] [Related]  

  • 29. Human proinsulin in insulin-treated juvenile diabetics.
    Heding LG; Ludvigsson J
    Acta Paediatr Scand Suppl; 1977; (270):48-52. PubMed ID: 278468
    [No Abstract]   [Full Text] [Related]  

  • 30. [Insulin antibodies and the actual insulin requirements in children and adolescents with primary diabetes].
    Karczewska K; Feluś E; Panek G; Otto-Buczkowska E; Dudziak Z
    Med Dosw Mikrobiol; 1974; 26(4):325-30. PubMed ID: 4475336
    [No Abstract]   [Full Text] [Related]  

  • 31. [Importance of immunological shifts in the development of diabetes mellitus and cardiovascular pathology in children and adolescents].
    Balabolkin MI; Sarana VA; Stuliĭ LA; Belozorova NI; Terebkova IV
    Vestn Akad Med Nauk SSSR; 1983; (2):33-9. PubMed ID: 6340363
    [No Abstract]   [Full Text] [Related]  

  • 32. Monocomponent insulin in maturity onset diabetes mellitus.
    Viswanathan M; Ramachandran A; Snehalatha C; Viswanathan M
    J Indian Med Assoc; 1981 Mar; 76(5):73-5. PubMed ID: 7021694
    [No Abstract]   [Full Text] [Related]  

  • 33. A prospective study of glucose profiles, insulin antibody levels and beta cells secretory patterns in non-obese Ugandan diabetic subjects.
    Otim MA
    East Afr Med J; 1988 Jan; 65(1):8-15. PubMed ID: 3046922
    [No Abstract]   [Full Text] [Related]  

  • 34. [Avidity and binding capacity of bovine and porcine insulin binding antibodies in childhood diabetes].
    Hürter P; Kühnau J
    Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):250-2. PubMed ID: 5535600
    [No Abstract]   [Full Text] [Related]  

  • 35. Increased circulating Ia-antigen-bearing T cells in type I diabetes mellitus.
    Jackson RA; Morris MA; Haynes BF; Eisenbarth GS
    N Engl J Med; 1982 Apr; 306(13):785-8. PubMed ID: 7038489
    [No Abstract]   [Full Text] [Related]  

  • 36. Insulin-binding antibodies in diabetic patients and their relationship to insulin treatment.
    Ditzov SP; Penchev IG; Andreev DC; Tarkolev NT; Sirakov LM
    Acta Diabetol Lat; 1974; 11(2):106-11. PubMed ID: 4432726
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of monocomponent insulin serum anti-insulin antibody levels (author's transl)].
    García de los Ríos M; Mella I; Durruty P; Ruiz F; López G; Tapia JC; González G
    Rev Med Chil; 1981 Jun; 109(6):509-15. PubMed ID: 7036310
    [No Abstract]   [Full Text] [Related]  

  • 38. [Determination of the insulin antibody titre in severe form of diabetes mellitus].
    Pliats OM; Alekseev IuP
    Probl Endokrinol (Mosk); 1977; 23(3):12-4. PubMed ID: 887624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of immune complexes in insulin-treated diabetics.
    Jayarao KS; Faulk WP; Karam JH; Grodsky GM; Forsham PH
    J Immunol Methods; 1973 Dec; 3(4):337-45. PubMed ID: 4591347
    [No Abstract]   [Full Text] [Related]  

  • 40. [Insulin antibodies in untreated and insulin-treated diabetics].
    Ditsov S; Penchev I; Andreev D; Sirakov L; Turkolev N
    Vutr Boles; 1972; 11(3):95-9. PubMed ID: 4679989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.